Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249581 (US9447038, 9) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249658 (US9447038, 86) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166453 (US9073853, 12) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166545 (US9073853, 104) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166446 (US9073853, 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249583 (US9447038, 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166528 (US9073853, 87) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249763 (US9447038, 191) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166447 (US9073853, 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249609 (US9447038, 37 | US9447038, 38) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249608 (US9447038, 36) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166475 (US9073853, 34) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249615 (US9447038, 43) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249577 (US9447038, 5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166529 (US9073853, 88) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249647 (US9447038, 75) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166466 (US9073853, 25) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166455 (US9073853, 14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166589 (US9073853, 148) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166477 (US9073853, 36) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249720 (US9447038, 148) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249696 (US9447038, 124) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249760 (US9447038, 188) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249659 (US9447038, 87) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249601 (US9447038, 29) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166450 (US9073853, 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249596 (US9447038, 24) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249574 (US9447038, 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249646 (US9447038, 74) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166457 (US9073853, 16) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166456 (US9073853, 15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166445 (US9073853, 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249717 (US9447038, 145 | US9447038, 177) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166448 (US9073853, 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249699 (US9447038, 127) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249598 (US9447038, 26) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249761 (US9447038, 189) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249587 (US9447038, 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249612 (US9447038, 40) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249572 (US9447038, 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249595 (US9447038, 23) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166474 (US9073853, 33) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249703 (US9447038, 131) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249713 (US9447038, 141) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249616 (US9447038, 44) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166458 (US9073853, 17) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249609 (US9447038, 37 | US9447038, 38) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166517 (US9073853, 76) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 3 (Homo sapiens (Human)) | BDBM166516 (US9073853, 75) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
SANOFI US Patent | Assay Description Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac... | US Patent US9073853 (2015) BindingDB Entry DOI: 10.7270/Q2Q23Z10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C motif chemokine 10 (Homo sapiens (Human)) | BDBM249656 (US9447038, 84) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | 25 |
Sanofi US Patent | Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con... | US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 362 total ) | Next | Last >> |